| Extent and magnitude of catecholamine surge in pediatric burned patients. | |
| | |
MedLine Citation:
|
PMID: 20407405 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Increased catecholamine (CA) levels after severe burn are associated with stress, inflammation, hypermetabolism, and impaired immune function. The CA secretion profiles in burned patients are not well described. Mechanisms, duration, and extent of CA surge are unknown. The purpose of this large unicenter study was to evaluate the extent and magnitude of CA surge after severe burn in pediatric patients. Patients admitted between 1996 and 2008 were enrolled in this study. Twenty-four-hour urine collections were performed during acute hospitalization and up to 2 years postburn. Results from the samples collected from 12 normal, healthy volunteers were compared with the data from the burned patients. Relevant demographic and clinical information was obtained from medical records. Student t-test and one-way ANOVA were used to analyze the data where appropriate. Significance was accepted at P < 0.05. Four hundred thirteen patients were enrolled in this study; 17 patients died during acute hospitalization. Burn caused a marked stress and inflammatory response, indicated by massive tachycardia and elevated proinflammatory cytokines. In burned patients, CA levels are consistently and significantly modulated after burn when compared with the levels in normal, healthy volunteers. Catecholamine levels were significantly higher in boys compared with girls, correlated with burn size in burns greater than 40%, and were increased in older children. There were differences over time in survivors versus nonsurvivors, with CA levels significantly higher in nonsurvivors at two time points. Inflammatory cytokines show a similar profile during the study period. Our study gives clinicians a useful insight into the extent and magnitude of CA elevation to better design treatment strategies. |
| | |
Authors:
|
Gabriela A Kulp; David N Herndon; Jong O Lee; Oscar E Suman; Marc G Jeschke |
Related Documents
:
|
8325075 - Gastric intramucosal ph. a better predictor of multiorgan dysfunction syndrome and deat... 19464975 - Matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with ... 10507595 - The patient-related costs of care for sepsis patients in a united kingdom adult general... 7618405 - Early enteral nutrition in severe burns. 12528025 - Post-extubation stridor in intensive care unit patients. risk factors evaluation and im... 8057125 - Peripheral neuropathy associated with primary sjögren's syndrome. |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
Journal Detail:
|
Title: Shock (Augusta, Ga.) Volume: 33 ISSN: 1540-0514 ISO Abbreviation: Shock Publication Date: 2010 Apr |
Date Detail:
|
Created Date: 2010-04-21 Completed Date: 2010-07-19 Revised Date: 2011-07-27 |
Medline Journal Info:
|
Nlm Unique ID: 9421564 Medline TA: Shock Country: United States |
Other Details:
|
Languages: eng Pagination: 369-74 Citation Subset: IM |
Affiliation:
|
Shriners Hospitals for Children, Department of Surgery, University Texas Medical Branch Galveston, Texas 77550, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Age Factors Burns / pathology, physiopathology*, urine Catecholamines / urine* Child Child, Preschool Cytokines / urine Dopamine / urine Epinephrine / urine Female Granulocyte Colony-Stimulating Factor / urine Heart Rate Humans Inflammation / physiopathology, urine Interleukin-6 / urine Interleukin-8 / urine Male Norepinephrine / urine Sex Factors Tumor Necrosis Factor-alpha / urine |
| Grant Support | |
ID/Acronym/Agency:
|
P50 GM060338-06/GM/NIGMS NIH HHS; P50 GM060338-060001/GM/NIGMS NIH HHS; P50 GM060338-069003/GM/NIGMS NIH HHS; P50 GM060338-069005/GM/NIGMS NIH HHS; P50 GM060338-090001/GM/NIGMS NIH HHS; P50 GM060338-09S1/GM/NIGMS NIH HHS; P50 GM60338/GM/NIGMS NIH HHS; R01 GM056687-10/GM/NIGMS NIH HHS; R01-GM56687/GM/NIGMS NIH HHS; T32 GM008256/GM/NIGMS NIH HHS; T32 GM008256-19/GM/NIGMS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Catecholamines; 0/Cytokines; 0/Interleukin-6; 0/Interleukin-8; 0/Tumor Necrosis Factor-alpha; 143011-72-7/Granulocyte Colony-Stimulating Factor; 51-41-2/Norepinephrine; 51-43-4/Epinephrine |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Relationship of basal heart rate variability to in vivo cytokine responses after endotoxin exposure.
Next Document: A model for evaluating the effects of blunt skeletal muscle trauma on microvascular permeability and...